- Zacks
What Makes Aptose Biosciences (APTO) a New Buy Stock
Aptose Biosciences (APTO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- Insider Monkey
Aptose Biosciences Inc. (NASDAQ:APTO) Q4 2023 Earnings Call Transcript
Aptose Biosciences Inc. (NASDAQ:APTO) Q4 2023 Earnings Call Transcript March 26, 2024 Aptose Biosciences Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name is Jonathan and I will be your conference operator today. I would like […]
- Zacks
Assertio (ASRT) Stock Plunges 65% in 3 Months: Here's Why
Assertio (ASRT) appears weighed down by the recent leadership transition. The company is also facing challenges with sales of its product franchisee of late.
